(Q34556023)

3 August 2017

1 reference

title

A systematic review of oral methotrexate for multiple sclerosis (English)

1 reference

3 August 2017

0 references

1 reference

1 reference

O M Gray

1

1 reference

PubMed ID

16900766

3 August 2017

G V McDonnell

series ordinal

2

1 reference

PubMed ID

16900766

3 August 2017

R B Forbes

series ordinal

3

1 reference

3 August 2017

1 August 2006

1 reference

Multiple Sclerosis Journal

3 August 2017

1 reference

3 August 2017

12

1 reference

3 August 2017

4

1 reference

3 August 2017

507-510

1 reference

The initiation of the autoimmune response in multiple sclerosis

3 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1299OA

Methotrexate: mechanism of action in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1299OA

The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1299OA

Possible role of histamine in pathogenesis of autoimmune diseases: implications for immunotherapy with histamine-2 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1299OA

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1299OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1299OA

Low dose oral methotrexate treatment of multiple sclerosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1299OA

Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1299OA

10.1191/1352458506MS1299OA

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

16900766